Breast Cancer Screening in Ghana - Trial NCT06362993
Access comprehensive clinical trial information for NCT06362993 through Pure Global AI's free database. This phase not specified trial is sponsored by Penn State University and is currently Not yet recruiting. The study focuses on Breast Cancer Female. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Penn State University
Timeline & Enrollment
N/A
Apr 01, 2024
Mar 01, 2025
Primary Outcome
Clinical breast exam (CBE) utilization at the local clinic
Summary
This study is designed to test the feasibility of two intervention on promoting early
 screening for breast cancer in rural Ghana. In one intervention, screening for breast cancer,
 diabetes and hypertension will be offered together. In another intervention, a series of
 sessions with men will be conducted with a goal to change gender attitudes and increase
 support to women. The investigators' long-term goal is to test these interventions in a
 large-scale randomized controlled trial. The specific aims of this feasibility study are to:
 1) refine the study materials, including the curriculum for the sessions with men, by
 consulting with an expert advisory committee and a local committee, and 2) determine the
 feasibility of the two interventions in four clinic zones in Yilo-Krobo district in eastern
 Ghana (1 clinic in control, 1 clinic in the first intervention, and 2 in the second
 intervention). This trial registration is for the second specific aim.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06362993
Non-Device Trial